Daily Briefing: EasyJet jobs at risk, Europe's €750bn stimulus doubts, GlaxoSmithKline's vaccine plan

28 May: Your round-up of the global issues leading today's agenda

28 May: Your round-up of the global issues leading today's agenda

  • EasyJet Plc will cut thousands of jobs representing as much as 30% of the workforce to cope with a long-term hit to demand from the coronavirus crisis, Bloomberg says. Europe’s second-biggest discount carrier will begin employee consultations in coming days, it said in a statement Thursday. The Luton, England-based firm has about 15,000 workers, suggesting 4,500 posts are at risk.

  • Brussels faces a critical few weeks for corralling member states to fall in behind an unprecedented boost to EU spending, betting that its proposal for €750bn of borrowing will unblock talks on the bloc’s next budget, the Financial Times says. While a number of capitals indicated that they saw the commission proposal as a workable basis for negotiations, there is a widespread recognition that prodigious hurdles remain in the way of a consensus. 

  • GlaxoSmithKline Plc plans to produce 1 billion doses of a vaccine adjuvant – a booster that can help any brand of shot – to support immunization against the Covid-19 pandemic next year, Bloomberg reports. The adjuvant can reduce the amount of vaccine required per dose, allowing more people to be immunized, and create longer-lasting immunity, Glaxo said in a statement Thursday. The U.K. drugmaker in April agreed to provide its technology to help develop an experimental vaccine with French pharma giant Sanofi.

  • The Spanish government proposed on Tuesday that the European Union open up travel routes between regions in the EU that have controlled the spread of the coronavirus, El País says. Tourism Minister Reyes Maroto made the proposal at a press conference following a Cabinet meeting, and the idea has already reached the European Commission.




Accenture's CEO and CFO interview by Leaders League Group

About us